Roche to buy LumiraDx’s technology platform for US$ 295 million

Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million

Adani and Sirius form JV to digitally transform India's digital economy

Sirius JV will be owned 51% by Sirius and 49% by Adani

Venus Remedies secures marketing approval from Israel, Colombia for two oncology drugs

The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia

Akums to empower mothers with Doxylamine + Pyridoxine extended-release tablets for severe morning sickness

This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy

Mandaviya virtually launches 'MedTech Mitra'

MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic

Sonowal and Khandu lay foundation stone for capacity expansion at NEIAFMR

NEIAFMR to be developed as the national hub for folk medicine

GenSci launches global innovation hub in Shanghai

The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges

Roche receives USFDA’s priority review to Xolair for food allergies based on positive NIH Phase III study results

If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure

Lupin Atlantis Holdings to acquire accretive established products in Europe and Canada from Sanofi

The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired

Natco Pharma and Breckenridge dismissed from antitrust lawsuit